Tag: depression

Psychiatry

Trial of #Psilocybin versus #Escitalopram for Depression

Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking. METHODS In a phase 2, double-blind, randomized, controlled trial involving patients with long-standing, moderate-to-severe major depressive disorder, we compared psilocybin with escitalopram, a selective serotonin-reuptake inhibitor, over a 6-week period. Patients were assigned in a 1:1 ratio to receive two separate doses of 25 mg of psilocybin 3 … Continue reading Trial of #Psilocybin versus #Escitalopram for Depression

Rate This

aledopress
Psychiatry

Acute cognitive effects of single-dose intravenous #ketamine in major #depressive and posttraumatic stress disorder

Intravenous (IV) subanesthetic doses of ketamine have been shown to reduce psychiatric distress in both major depressive (MDD) and posttraumatic stress disorder (PTSD). However, the effect of ketamine on cognitive function in these disorders is not well understood. To address this gap, we examined the effect of a single dose of IV ketamine on cognition in individuals with MDD and/or PTSD relative to healthy controls … Continue reading Acute cognitive effects of single-dose intravenous #ketamine in major #depressive and posttraumatic stress disorder

Rate This

aledopress
Psychiatry

Jumping to conclusions and #suicidal behavior in #depression and #psychosis

Highlights • Presence of JTC is higher in depressive and psychotic patients with history of SB, specially under ambiguous conditions. • Within individuals who exhibited JTC, more had a diagnosis of depression than psychosis, and that is related to older age. • JTC might be considered a transdiagnostic construct present in different psychiatric disorders. Abstract Suicidal behavior (SB) involves an impairment in decision-making (DM). Jumping … Continue reading Jumping to conclusions and #suicidal behavior in #depression and #psychosis

Rate This

aledopress
Psychiatry

Effects of Stressful Events and Perceived #Stress on Cognitive Change Among #Depressed Older Adults

Stress is thought to exacerbate cognitive decline in older adults, especially those with late life depression (LLD); however, the specific aspects of stress that are especially deleterious and the aspects of cognition they affect are not clear. For example, it is not known whether the effects result from the exposure to stressful life events or whether it is the perception of stress that is salient, … Continue reading Effects of Stressful Events and Perceived #Stress on Cognitive Change Among #Depressed Older Adults

Rate This

aledopress
Cardiology, Gerontology, Neurology

A Primary Care Agenda for #Brain Health: A Scientific Statement From the American Heart Association

A healthy brain is critical for living a longer and fuller life. The projected aging of the population, however, raises new challenges in maintaining quality of life. As we age, there is increasing compromise of neuronal activity that affects functions such as cognition, also making the brain vulnerable to disease. Once pathology-induced decline begins, few therapeutic options are available. Prevention is therefore paramount, and primary … Continue reading A Primary Care Agenda for #Brain Health: A Scientific Statement From the American Heart Association

Rate This

aledopress
Cardiology, Psychiatry

Do #β-Blockers Cause #Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy

β-Blockers are important drugs in the treatment of cardiovascular diseases. They are suspected of inducing various psychiatric adverse events (PAEs), particularly depression, affecting cardiovascular morbidity and mortality. We performed a systematic search for double-blind, randomized controlled trials investigating β-blockers to analyze the risk of PAEs or withdrawal of therapy due to PAEs. We extracted the frequencies of PAEs and rates of withdrawals and reviewed them … Continue reading Do #β-Blockers Cause #Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy

Rate This

aledopress
Diet, Psychiatry

Common and specific aspects of #anxiety and #depression and the #metabolic syndrome

The associations of anxiety and depression with metabolic syndrome (MetS) are not consistent across studies. Anxiety and depression are highly correlated and traditional methods don’t take the structure of this correlation into account. Our aim is to disentangle the relationship of these emotional conditions with MetS, using bifactor models, modelling both general and specific aspects between anxiety and depression. Methods Bifactor models were tested using … Continue reading Common and specific aspects of #anxiety and #depression and the #metabolic syndrome

Rate This

aledopress
Diet, Gerontology

An integrative study of five biological #clocks in somatic and mental #health

Biological clocks have been developed at different molecular levels and were found to be more advanced in the presence of somatic illness and mental disorders. However, it is unclear whether different biological clocks reflect similar aging processes and determinants. In ~3000 subjects, we examined whether five biological clocks (telomere length, epigenetic, transcriptomic, proteomic, and metabolomic clocks) were interrelated and associated to somatic and mental health … Continue reading An integrative study of five biological #clocks in somatic and mental #health

Rate This

aledopress
Cardiology, Psychiatry

Risk of #Cardiovascular Disease Mortality in Relation to #Depression and 14 Common Risk Factors

Depression has been linked to a worse prognosis of Cardiovascular disease (CVD), and these two diseases share a variety of common risk factors such as unhealthy lifestyles and chronic medical conditions. However, the potential role of these common risk factors in modulating the association between depression and CVD mortality and whether the co-occurrence of depression and a specific common risk factor has a cumulative impact … Continue reading Risk of #Cardiovascular Disease Mortality in Relation to #Depression and 14 Common Risk Factors

Rate This

aledopress
Diet, Infectivology, Psychiatry

Increased #alcohol use during the #COVID-19 pandemic: The effect of mental health and age in a cross-sectional sample of social media users in the U.S.

The COVID-19 pandemic has triggered a public health crisis of unprecedented scale. Increased alcohol use has been extensively documented during other crises, particularly among persons with anxiety and depression. Despite COVID-19’s differential impact by age, the association of age, mental health and alcohol use during the pandemic has not been explored. This study aimed to examine whether age modified the association of anxiety and depressive … Continue reading Increased #alcohol use during the #COVID-19 pandemic: The effect of mental health and age in a cross-sectional sample of social media users in the U.S.

Rate This

aledopress
Neurology, Psychiatry

State-dependent responses to intracranial brain stimulation in a patient with #depression

Deep brain stimulation is a promising treatment for severe depression, but lack of efficacy in randomized trials raises questions regarding anatomical targeting. We implanted multi-site intracranial electrodes in a severely depressed patient and systematically assessed the acute response to focal electrical neuromodulation. We found an elaborate repertoire of distinctive emotional responses that were rapid in onset, reproducible, and context and state dependent. Results provide proof … Continue reading State-dependent responses to intracranial brain stimulation in a patient with #depression

Rate This

aledopress
Infectivology, Neurology, Psychiatry

6-month consequences of #COVID-19 in patients discharged from hospital: a cohort study

The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.. ..In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0–65·0) … Continue reading 6-month consequences of #COVID-19 in patients discharged from hospital: a cohort study

Rate This

aledopress